304 results on '"De Giovanni, Carla"'
Search Results
2. Evolution of HER2-positive mammary carcinoma: HER2 loss reveals claudin-low traits in cancer progression
3. DRAL Is a p53-Responsive Gene Whose Four and a Half LIM Domain Protein Product Induces Apoptosis
4. Supplementary Methods from A Better Immune Reaction to Erbb-2 Tumors Is Elicited in Mice by DNA Vaccines Encoding Rat/Human Chimeric Proteins
5. Supplementary Figure 1 from In silico Modeling and In vivo Efficacy of Cancer-Preventive Vaccinations
6. Supplementary Figure 7 from A Better Immune Reaction to Erbb-2 Tumors Is Elicited in Mice by DNA Vaccines Encoding Rat/Human Chimeric Proteins
7. Supplementary Figure 5 from A Mutation Threshold Distinguishes the Antitumorigenic Effects of the Mitochondrial Gene MTND1, an Oncojanus Function
8. Supplementary Figure 6 from A Better Immune Reaction to Erbb-2 Tumors Is Elicited in Mice by DNA Vaccines Encoding Rat/Human Chimeric Proteins
9. Data from A Better Immune Reaction to Erbb-2 Tumors Is Elicited in Mice by DNA Vaccines Encoding Rat/Human Chimeric Proteins
10. Supplementary Figure 8 from A Better Immune Reaction to Erbb-2 Tumors Is Elicited in Mice by DNA Vaccines Encoding Rat/Human Chimeric Proteins
11. Supplementary Figure 1 from A Better Immune Reaction to Erbb-2 Tumors Is Elicited in Mice by DNA Vaccines Encoding Rat/Human Chimeric Proteins
12. Supplementary Figure 5 from A Better Immune Reaction to Erbb-2 Tumors Is Elicited in Mice by DNA Vaccines Encoding Rat/Human Chimeric Proteins
13. Data from In silico Modeling and In vivo Efficacy of Cancer-Preventive Vaccinations
14. Supplementary Figure Legends 1-4, Tables Legends 1-8 from A Better Immune Reaction to Erbb-2 Tumors Is Elicited in Mice by DNA Vaccines Encoding Rat/Human Chimeric Proteins
15. Data from A Mutation Threshold Distinguishes the Antitumorigenic Effects of the Mitochondrial Gene MTND1, an Oncojanus Function
16. Supplementary Figure Legend from In silico Modeling and In vivo Efficacy of Cancer-Preventive Vaccinations
17. Supplementary Figure 3 from A Mutation Threshold Distinguishes the Antitumorigenic Effects of the Mitochondrial Gene MTND1, an Oncojanus Function
18. Supplementary Figure 2 from A Mutation Threshold Distinguishes the Antitumorigenic Effects of the Mitochondrial Gene MTND1, an Oncojanus Function
19. Supplementary Figure 2 from A Better Immune Reaction to Erbb-2 Tumors Is Elicited in Mice by DNA Vaccines Encoding Rat/Human Chimeric Proteins
20. Supplementary Methods from In silico Modeling and In vivo Efficacy of Cancer-Preventive Vaccinations
21. Supplementary Figure 1 from A Mutation Threshold Distinguishes the Antitumorigenic Effects of the Mitochondrial Gene MTND1, an Oncojanus Function
22. Supplementary Figure 3 from A Better Immune Reaction to Erbb-2 Tumors Is Elicited in Mice by DNA Vaccines Encoding Rat/Human Chimeric Proteins
23. Data from Immunoprevention of HER-2/neu Transgenic Mammary Carcinoma through an Interleukin 12-Engineered Allogeneic Cell Vaccine
24. Supplementary Figure 4 from A Mutation Threshold Distinguishes the Antitumorigenic Effects of the Mitochondrial Gene MTND1, an Oncojanus Function
25. Supplementary Figure 4 from A Better Immune Reaction to Erbb-2 Tumors Is Elicited in Mice by DNA Vaccines Encoding Rat/Human Chimeric Proteins
26. Supplementary Tables 1-4 from In silico Modeling and In vivo Efficacy of Cancer-Preventive Vaccinations
27. Supplementary Figure from Immunoprevention of HER-2/neu Transgenic Mammary Carcinoma through an Interleukin 12-Engineered Allogeneic Cell Vaccine
28. Supplementary Methods and Figure Legends from A Mutation Threshold Distinguishes the Antitumorigenic Effects of the Mitochondrial Gene MTND1, an Oncojanus Function
29. Re: Randomized Trial of Adjuvant Human Interferon Gamma Versus Observation in High-Risk Cutaneous Melanoma: a Southwest Oncology Group Study
30. Immune targeting of autocrine IGF2 hampers rhabdomyosarcoma growth and metastasis
31. Inhibition of Human Tumor Growth in Mice by an Oncolytic Herpes Simplex Virus Designed to Target Solely HER-2-positive Cells
32. HER Tyrosine Kinase Family and Rhabdomyosarcoma: Role in Onset and Targeted Therapy
33. Tamoxifen combined to anti-HER-2/neu cell vaccine does not hamper cancer immunopreventive efficacy
34. 2011: the immune hallmarks of cancer
35. Different mtDNA mutations modify tumor progression in dependence of the degree of respiratory complex I impairment
36. Preclinical vaccines against mammary carcinoma
37. Expression of connective tissue growth factor (CTGF/CCN2) in a mouse model of rhabdomyosarcomagenesis
38. Immune prevention of mammary carcinogenesis in HER-2/neu transgenic mice: a microarray scenario
39. HERPESVIRUSES AS ONCOLYTIC AGENTS
40. Immunotherapy
41. The expression of P-glycoprotein is causally related to a less aggressive phenotype in human osteosarcoma cells
42. Immunoprevention and Immunotherapy of Mammary Carcinoma
43. Inhibition of Lung Colonisation of a Mouse Mammary Carcinoma by Therapeutic Vaccination with Interferon-α Gene-Transduced Tumor Cells
44. Inhibition of prostate carcinogenesis by combined active immunoprophylaxis
45. Establishment and characterization of a new cell line from primary human breast carcinoma
46. Concordant morphologic and gene expression data show that a vaccine halts HER-2/neu preneoplastic lesions
47. Cancer Vaccines Co-Targeting HER2/Neu and IGF1R
48. Interleukin 12-mediated Prevention of Spontaneous Mammary Adenocarcinomas in Two Lines of Her-2/neu Transgenic Mice
49. The prospects for cancer gene therapy
50. Concomitant Amplif ication and Expression of PAX7-FKHR and MYCN in a Human Rhabdomyosarcoma Cell Line Carrying a Cryptic t(1;13)(p36;q14)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.